Elevation of antibody against Epstein-Barr virus genes BRLF1 and BZLF1 in nasopharyngeal carcinoma Tomokazu YoshizakiHiroko MiwaMitsuru Furukawa ORIGINAL PAPER Pages: 69 - 73
Increased antitumour activity of mesyl-I-aldophosphamide-perhydrothiazine, in vivo but not in vitro, compared to I-aldophosphamide-perhydrothiazine G. VoelckerB. PfeifferH. -J. Hohorst ORIGINAL PAPER Pages: 74 - 78
Truncated TSG101 transcripts in human leukemia and lymphoma cell lines Yoshitaka HosokawaEmiko NagaiMasao Seto ORIGINAL PAPER Pages: 79 - 84
Effects of all-trans retinoic acid and epidermal growth factor on the expression of nm23-H1 in human hepatocarcinoma cells Fei LiuHui-Ling QiHui-Li Chen ORIGINAL PAPER Pages: 85 - 90
The two-receptor system PAR-1/PAR-4 mediates α-thrombin-induced [Ca2+]i mobilization in human astrocytoma cells R. KaufmannS. PattG. Nowak ORIGINAL PAPER Pages: 91 - 94
Collision tumour in the pelvic cavity: rectal leiomyosarcoma and prostate adenocarcinoma Jasminka PavelićJanez LamovecKrešimir Pavelić ORIGINAL PAPER Pages: 95 - 100
Serum levels of soluble CD30 in autologous peripheral blood stem cell transplantation Minori NagahamaShosaku NomuraShirou Fukuhara ORIGINAL PAPER Pages: 101 - 106
Serum protein S100β in patients with malignant melanoma detected by an immunoluminometric assay Uwe WollinaKerstin KarteClaudia Herold ORIGINAL PAPER Pages: 107 - 110
In vitro effect of multidrug resistance modifiers on idarubicinol efflux in blasts of acute myeloid leukemia Jan K. SchröderSabine Kasimir-BauerMax E. Scheulen ORIGINAL PAPER Pages: 111 - 116
p53-targeted drugs: intelligent weapons in the tumor-suppressing arsenal Athanasios G. Papavassiliou LETTER TO THE EDITORS Pages: 117 - 118
